HCA Healthcare, Inc.
HCANYSECIK 860730HealthcareFiscal year ends Dec 31
Latest reported revenue, Q3 FY2026$19.85bnRevenue, Q3 FY2026, three months to 2026-09-30$19.85bn. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001193125-26-437871.Report this figureThree months to Sep 30, 2026, from the 10-Q filed Oct 29, 2026.Latest quarter: Q3 FY2026
Three months to Sep 30, 2026, against the same quarter a year earlier.
- Revenue$19.85bnRevenue, Q3 FY2026, three months to 2026-09-30$19.85bn. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001193125-26-437871.Report this figure+3.6% on a year earlier - Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
- Operating marginnot reported (Operating income not reported)No year-earlier figure to compare
- Net margin8.0%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $1.58bn. XBRL concept
us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001193125-26-437871.Revenue: $19.85bn. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001193125-26-437871.Report this figure−0.6 pts on a year earlier - Diluted EPS$7.27Diluted EPS, Q3 FY2026, three months to 2026-09-30$7.27 per share. XBRL concept
us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001193125-26-437871.Report this figure+4.5% on a year earlier - Free cash flow$3.10bnFree cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $4.46bn. XBRL concept
us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001193125-26-437871. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.36bn. XBRL conceptus-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001193125-26-437871. Derived: 9-month figure less the 6-month figure.Report this figure−0.8% on a year earlier
Last eight quarters
Full statements| Line item | Unit | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 | Q3 FY20262026-09-30 | Shape over the periods |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $bn | 18.3Revenue, Q4 FY2024, three months to 2024-12-31$18.29bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001193125-26-044769. Derived: 12-month figure less the 9-month figure.Report this figure | 18.3Revenue, Q1 FY2025, three months to 2025-03-31$18.32bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0001193125-26-191444.Report this figure | 18.6Revenue, Q2 FY2025, three months to 2025-06-30$18.61bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-28, accession 0001193125-26-321077.Report this figure | 19.2Revenue, Q3 FY2025, three months to 2025-09-30$19.16bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001193125-26-437871.Report this figure | 19.5Revenue, Q4 FY2025, three months to 2025-12-31$19.51bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001193125-26-044769. Derived: 12-month figure less the 9-month figure.Report this figure | 19.1Revenue, Q1 FY2026, three months to 2026-03-31$19.11bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0001193125-26-191444.Report this figure | 20.2Revenue, Q2 FY2026, three months to 2026-06-30$20.23bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-28, accession 0001193125-26-321077.Report this figure | 19.8Revenue, Q3 FY2026, three months to 2026-09-30$19.85bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001193125-26-437871.Report this figure | |
| Gross margin | % | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | |
| Operating margin | % | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | |
| Net margin | % | 7.9%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $1.44bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001193125-26-044769. Derived: 12-month figure less the 9-month figure.Revenue: $18.29bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001193125-26-044769. Derived: 12-month figure less the 9-month figure.Report this figure | 8.8%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $1.61bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0001193125-26-191444.Revenue: $18.32bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0001193125-26-191444.Report this figure | 8.9%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $1.65bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-28, accession 0001193125-26-321077.Revenue: $18.61bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-28, accession 0001193125-26-321077.Report this figure | 8.6%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $1.64bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001193125-26-437871.Revenue: $19.16bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001193125-26-437871.Report this figure | 9.6%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $1.88bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001193125-26-044769. Derived: 12-month figure less the 9-month figure.Revenue: $19.51bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001193125-26-044769. Derived: 12-month figure less the 9-month figure.Report this figure | 8.5%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $1.62bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0001193125-26-191444.Revenue: $19.11bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0001193125-26-191444.Report this figure | 8.4%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $1.70bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-28, accession 0001193125-26-321077.Revenue: $20.23bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-28, accession 0001193125-26-321077.Report this figure | 8.0%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $1.58bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001193125-26-437871.Revenue: $19.85bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001193125-26-437871.Report this figure | |
| Diluted EPS | $ per share | not reported (Diluted EPS not reported) | 6.45Diluted EPS, Q1 FY2025, three months to 2025-03-31$6.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001193125-26-191444.Report this figure | 6.83Diluted EPS, Q2 FY2025, three months to 2025-06-30$6.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-28, accession 0001193125-26-321077.Report this figure | 6.96Diluted EPS, Q3 FY2025, three months to 2025-09-30$6.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001193125-26-437871.Report this figure | not reported (Diluted EPS not reported) | 7.15Diluted EPS, Q1 FY2026, three months to 2026-03-31$7.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001193125-26-191444.Report this figure | 7.62Diluted EPS, Q2 FY2026, three months to 2026-06-30$7.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-28, accession 0001193125-26-321077.Report this figure | 7.27Diluted EPS, Q3 FY2026, three months to 2026-09-30$7.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001193125-26-437871.Report this figure | |
| Free cash flow | $bn | 1.3Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $2.56bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001193125-26-044769. Derived: 12-month figure less the 9-month figure.Capital expenditure: $1.28bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001193125-26-044769. Derived: 12-month figure less the 9-month figure.Report this figure | 0.7Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $1.65bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0001193125-26-191444.Capital expenditure: $991.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-29, accession 0001193125-26-191444.Report this figure | 3.0Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $4.21bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-28, accession 0001193125-26-321077. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.18bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-28, accession 0001193125-26-321077. Derived: 6-month figure less the 3-month figure.Report this figure | 3.1Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $4.42bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001193125-26-437871. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.29bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001193125-26-437871. Derived: 9-month figure less the 6-month figure.Report this figure | 0.9Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $2.36bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001193125-26-044769. Derived: 12-month figure less the 9-month figure.Capital expenditure: $1.49bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001193125-26-044769. Derived: 12-month figure less the 9-month figure.Report this figure | 0.9Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $2.01bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0001193125-26-191444.Capital expenditure: $1.12bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-29, accession 0001193125-26-191444.Report this figure | 1.1Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $2.33bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-28, accession 0001193125-26-321077. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.23bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-28, accession 0001193125-26-321077. Derived: 6-month figure less the 3-month figure.Report this figure | 3.1Free cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $4.46bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001193125-26-437871. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.36bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001193125-26-437871. Derived: 9-month figure less the 6-month figure.Report this figure |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Last five fiscal years
| Line item | Unit | FY20212021-12-31 | FY20222022-12-31 | FY20232023-12-31 | FY20242024-12-31 | FY20252025-12-31 | Shape over the periods |
|---|---|---|---|---|---|---|---|
| Revenue | $bn | 58.8Revenue, FY2021, twelve months to 2021-12-31$58.75bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-16, accession 0000950170-24-016524.Report this figure | 60.2Revenue, FY2022, twelve months to 2022-12-31$60.23bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-14, accession 0000950170-25-020134.Report this figure | 65.0Revenue, FY2023, twelve months to 2023-12-31$64.97bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001193125-26-044769.Report this figure | 70.6Revenue, FY2024, twelve months to 2024-12-31$70.60bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001193125-26-044769.Report this figure | 75.6Revenue, FY2025, twelve months to 2025-12-31$75.60bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001193125-26-044769.Report this figure | |
| Gross margin | % | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | |
| Operating margin | % | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | |
| Net margin | % | 11.8%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $6.96bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-16, accession 0000950170-24-016524.Revenue: $58.75bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-16, accession 0000950170-24-016524.Report this figure | 9.4%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $5.64bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-14, accession 0000950170-25-020134.Revenue: $60.23bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-14, accession 0000950170-25-020134.Report this figure | 8.1%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $5.24bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001193125-26-044769.Revenue: $64.97bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001193125-26-044769.Report this figure | 8.2%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $5.76bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001193125-26-044769.Revenue: $70.60bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001193125-26-044769.Report this figure | 9.0%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $6.78bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001193125-26-044769.Revenue: $75.60bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001193125-26-044769.Report this figure | |
| Diluted EPS | $ per share | 21.16Diluted EPS, FY2021, twelve months to 2021-12-31$21.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-16, accession 0000950170-24-016524.Report this figure | 19.15Diluted EPS, FY2022, twelve months to 2022-12-31$19.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-14, accession 0000950170-25-020134.Report this figure | 18.97Diluted EPS, FY2023, twelve months to 2023-12-31$18.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-10, accession 0001193125-26-044769.Report this figure | 22.00Diluted EPS, FY2024, twelve months to 2024-12-31$22.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-10, accession 0001193125-26-044769.Report this figure | 28.33Diluted EPS, FY2025, twelve months to 2025-12-31$28.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-10, accession 0001193125-26-044769.Report this figure | |
| Free cash flow | $bn | 5.4Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $8.96bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-16, accession 0000950170-24-016524.Capital expenditure: $3.58bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-16, accession 0000950170-24-016524.Report this figure | 4.1Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $8.52bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-14, accession 0000950170-25-020134.Capital expenditure: $4.39bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-14, accession 0000950170-25-020134.Report this figure | 4.7Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $9.43bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001193125-26-044769.Capital expenditure: $4.74bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001193125-26-044769.Report this figure | 5.6Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $10.51bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001193125-26-044769.Capital expenditure: $4.88bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001193125-26-044769.Report this figure | 7.7Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $12.64bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001193125-26-044769.Capital expenditure: $4.94bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001193125-26-044769.Report this figure |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2016-05-10 | Kravis Henry R10% owner | Sale | 332,799 | $80.12 | $26.7m | Form 4 |
| 2016-05-10 | Kravis Henry R10% owner | Sale | 381,309 | $80.12 | $30.6m | Form 4 |
| 2016-05-10 | Kravis Henry R10% owner | Sale | 78,529 | $80.12 | $6.3m | Form 4 |
| 2016-05-10 | Kravis Henry R10% owner | Sale | 127,923 | $80.12 | $10.2m | Form 4 |
| 2016-05-10 | Kravis Henry R10% owner | Sale | 1,249,115 | $80.12 | $100.1m | Form 4 |
| 2016-05-10 | Kravis Henry R10% owner | Sale | 3,461,161 | $80.12 | $277.3m | Form 4 |
| 2016-05-10 | Kravis Henry R10% owner | Sale | 3,730,122 | $80.12 | $298.9m | Form 4 |
| 2012-04-03 | Bank of America Corp10% owner | Sale | 300 | $26.83 | $8.0k | Form 4 |
| 2012-04-03 | Bank of America Corp10% owner | Sale | 112 | $26.83 | $3.0k | Form 4 |
| 2012-03-19 | Bank of America Corp10% owner | Purchase | 25 | $25.18 | $629.50 | Form 4 |
| 2012-03-16 | Bank of America Corp10% owner | Sale | 25 | $25.33 | $633.25 | Form 4 |
| 2012-03-15 | Bank of America Corp10% owner | Sale | 2 | $25.34 | $50.68 | Form 4 |
| 2012-03-09 | Bank of America Corp10% owner | Purchase | 2 | $25.63 | $51.26 | Form 4 |
| 2012-03-08 | Bank of America Corp10% owner | Sale | 100 | $25.315 | $2.5k | Form 4 |
| 2012-03-08 | Bank of America Corp10% owner | Sale | 100 | $25.315 | $2.5k | Form 4 |
| 2012-03-08 | Bank of America Corp10% owner | Sale | 1,300 | $25.3147 | $32.9k | Form 4 |
| 2012-03-08 | Bank of America Corp10% owner | Sale | 80 | $25.31 | $2.0k | Form 4 |
| 2012-03-08 | Bank of America Corp10% owner | Purchase | 1,580 | $25.28 | $39.9k | Form 4 |
| 2012-02-22 | Bank of America Corp10% owner | Purchase | 200 | $25.4637 | $5.1k | Form 4 |
| 2012-02-22 | Bank of America Corp10% owner | Sale | 200 | $25.4089 | $5.1k | Form 4 |
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2026-06-30 | $5.07bn | 13,003,600 | Reduced−359,666 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2026-06-30 | $3.95bn | 10,141,708 | Reduced−36,654 | |
| Sanders Capital, LLC | 2026-06-30 | $3.44bn | 8,828,287 | Reduced−128,858 | |
| STATE STREET CORP | 2026-06-30 | $2.91bn | 7,469,035 | Reduced−70,515 | |
| WELLINGTON MANAGEMENT GROUP LLP | 2026-06-30 | $1.84bn | 4,707,473 | Added+799,761 | |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-06-30 | $1.42bn | 3,668,008 | Reduced−24,505 | |
| First Eagle Investment Management, LLC | 2026-06-30 | $1.28bn | 3,295,565 | Added+40,995 | |
| First Eagle Investment Management, LLC | 2026-06-30 | $1.28bn | 3,295,565 | Added+40,995 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2026-06-30 | $1.06bn | 2,712,828 | Reduced−44,951 | |
| MORGAN STANLEY | 2026-06-30 | $1.01bn | 2,586,771 | Added+291,891 |
Recent filings
All 2,306 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:30 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001193125-26-437871 |
| 2026-10-2707:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-432665 |
| 2026-07-2916:10 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events | 0001193125-26-323731 |
| 2026-07-2816:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-321077 |
| 2026-07-2407:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-315151 |
| 2026-07-1407:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-302539 |
| 2026-06-1809:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-275086 |
| 2026-04-3016:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-197278 |
| 2026-04-2916:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-191444 |
| 2026-04-2816:20 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-187155 |
Latest annual report
Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 10, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.
Forecast league
Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league
About the filer
- CIK
- 860730
- Tickers
- HCA
- Exchange
- NYSE
- SIC code
- 8062 Services-General Medical & Surgical Hospitals, NEC
- Sector
- Healthcare
- Fiscal year ends
- Dec 31
- Incorporated in
- not reported
- Filer category
- Large accelerated filer
- Former names
- HCA Holdings, Inc. (to 2017-05-05); HCA INC/TN (to 2010-11-24); HCA THE HEALTHCARE CO (to 2001-05-21); HCA-THE HEALTHCARE CO (to 2001-02-14); COLUMBIA HCA HEALTHCARE CORP (to 2000-05-19); COLUMBIA HCA HEALTHCARE CORP/ (to 2000-02-16); COLUMBIA HEALTHCARE CORP (to 1994-03-01)
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 18:36 ET. Listed shows no prices and gives no investment advice.